DINKY
8 evidence topics · 2 sources
Objective
Pediatric treatment objective
Location and study date
Planned United Kingdom site
Study design
Eligibility criteria
Age eligibility
Treatment
Timing of imlifidase treatment
Study outcomes
Rationale for using crossmatch conversion as the primary endpoint
Crossmatch conversion rationale
Statistical analysis description
Number of participants (Planned and analyzed)
Planned enrollment in the research summary
| Population | Participants |
|---|---|
| Planned | “10” |
Description of analysis sets
No evidence found.
Results
Participant disposition
No evidence found.
Baseline characteristics
No evidence found.
Efficacy results
No evidence found.
Health-related quality of life and patient-reported outcomes
No evidence found.
Safety results
No evidence found.
Study limitations
Summary
The research summary describes a single-arm pediatric trial with planned enrollment of 10 participants aged 1 to 17 years. This design does not provide a randomized comparator. No study results are included in this report, so the planned study cannot establish pediatric efficacy or safety here.